Polymorphonuclear leukocytes (PMN)' have been demonstrated to exhibit a cytotoxic activity against tumor cells in vitro (1) , as well as other immune cells, including cytotoxic lymphocytes, NK cells, and macrophages (2, 3) . For cellular immune reaction against tumor cells, these immune cells migrate to tumor-growing sites for attacking tumor cells, thus implying a possibility that tumor cells might produce a chemotactic factor for immune cells. In this regard, Bottazzi et al. (4) have reported that the neoplastic cells of mouse or human origin produce chemotactic factors for macrophages and there is a positive correlation between production ofthe factors by tumor cells and the amount of macrophage infiltration in tumor tissues. It may be assumed that PMN migrate to tumor-growing sites responding to tumor-producing chemotactic factors before the migration of any other immune cells, since PMN infiltration into inflammatory sites has been demonstrated to occur at the earliest stage of infection (5) . In some surgical specimens, PMN infiltration has been observed in the primary tissue of tumors . Infiltration of PMN has also been demonstrated in lung giant cell carcinoma (6) . This observation has suggested that the tumor cells might release extracellularly a PMN chemotactic factor. This paper describes the purification ofPMN chemotactic protein (lung carcinomaderived chemotaxin [LUCT] ) from the culture fluid of the human lung giant cell carcinoma cell line LU65C (6) , and some characterization of LUCT, including NH2-terminal partial amino acid sequence and amino acid composition. Comparison ofamino acid sequences was made between LUCT and other reported chemotactic factors and protein deduced from the 3-10C cDNA .
Materials and Methods LU65C cells (clone C of LU65 cell line) were cultured in 50 ml of Iscove's modified Dulbecco's medium containing 0.1% BSA supplemented with 100 U/ml penicillin G, 100 Ag/ml streptomycin, and 0.3% sodium bicarbonate without FCS in a 75-cm' flask . After 4 d of cultivation, the culture fluid was harvested and centrifuged for 10 min at 1,500 g at 4°C. The cells were cultured another 4 d with 50 ml of the fresh medium and the culture fluid was again similarly harvested. Thus, 51.9 liters in a total volume of the culture fluid was frozen at -80°C in 200 packages . Buffer solutions were used as follows : buffer A, 50 mM sodium phosphate buffer (pH 7 .4); buffer B, 0.005% BSA (81-028; Miles Scientific Div., Naperville, IL) was contained in buffer A; buffer C, 0.001% BSA was contained in buffer A; buffer D, 1.0 M NaCl was contained in buffer B; and buffer E, 20 mM sodium phosphate buffer (pH 7 .4). All labware was rinsed with buffer B or C to avoid nonspecific adsorption of LUCT. After 2.5-3 liters of the culture fluid was thawed and dialized overnight against water in membrane tubings (mol wt 3,500) (Por3; Spectrum Medical, Los Angeles, CA), the fluid was mixed with 150 ml of DEAE-Sepharose CL6B equilibrated with the buffer A and gently stirred for 2 h at 4°C . Then the resin was filtered off on a Kiriyama Roto funnel. After CM-Sepharose CL6B equilibrated with buffer B as 50 ml slurry (10-ml gel volume) was added to the filtrate and stirred for 3 h at 4°C, the resin was collected by aspirating with a bottle top filter (7105; Falcon Labware, Oxnard, CA) . After washing the gel with 75 ml of buffer B, protein adsorbed on the gel was eluted with 30 ml of buffer D. Thus, the 3 liters of culture filtrate was concentrated to 30 ml. The concentrated crude LUCT solution was frozen at -80°C until for further purification. These procedures were repeated 21 times for concentration ofa total of 51.9 liters of culture fluid. A total of 750 ml of concentrated crude LUCT solution was centrifuged for 15 min at 3,000 rpm at VC to eliminate insoluble materials and was dialyzed against 15 liters ofbuffer A overnight. Successively, LUCT was purified by carboxyl-methylatedpolyvinylalcohol resin, hydrophobic resin, and reversed-phase column on HPLC . SDS-PAGE was carried out by the method of Laemmli (7) using 1.3 Ag of LUCT. Isoelectric point (pI) of LUCT was determined by chromatofocusing . LUCT solution containing 0.005% BSA dialyzed against 25 mM triethylamine HCl buffer (pH 11.0) was applied to a polybuffer exchanger PBE 118 column (1.0 ¢ x 15 cm) (Pharmacia Fine Chemicals, Uppsala, Sweden) equilibrated with 25 mM triethylamine HCl buffer (pH 11 .0); the column was eluted with 225 ml of diluted Pharmalyte (1/45, pH 8.0) at a flow rate of 45 ml/h. Amino acid analysis ofLUCT (8.5 jug) was performed by an amino acid analyzer (6300E ; Beckman Instruments, Inc., Fullerton, CA) after hydrolysis with 0.5 ml of 6N HCl in an evacuated sealed tube for 24 h at 110 0C. NH2-terminal sequence of LUCT (3 .8 Wg) was directly determined with a gasphase peptide sequencer (477A; Applied Biosystems, Inc., Foster City, CA) . Migration activity of PMN was determined by the migration distance in a filter (3 Am in pore size) (Millipore Continental Water Systems, Bedford, MA) using a modified Boyden chamber method (8) . Assay samples at each purification step were dialyzed against 5.0 liters of PBS(-) overnight before assay. All samples were diluted to one half with a chemotaxis medium, which consisted of 257o BSA, 1.25 mM CaC12, 0.49 MM MgCl2, 0.41 MM MgS04, 0.1% glucose, and 0.6% NaHCO3 . The diluted sample was placed into the lower compartment of the chamber, and human PMN suspension (2 x 106 cells/ml) was placed in a mixture of PBS(-) and chemotaxis medium (1 :1) into the upper compartment and then incubated for 35 min at 37°C under 5% C02 in air. The leading front distance was expressed as a mean of values of the final concentration of the sample determined in five microscopic fields. Chemotactic unit of LUCT was calculated from three parameters; FMLP (10 -8 M)-stimulated maximal migration (FM), minimal migration without chemotactic factor, termed random migration (RM), and migration induced by LUCT sample (SM). Chemotactic migration unit (CTU) was defined as 100 x (SM -RM)/(FM -RM). Total CTU in each step was calculated by multiplying the dilution of a sample for 50 CTU in the dilution-activity curve .
Results and Discussion
We purified 35 hg ofLUCT as a single peak by a reversed-phase column on HPLC in the final step (Fig. 1) . Table I summarizes the results of purification of LUCT. 
.0 M ammonium sulfate . LUCT activity was eluted with a linear gradient of 2.0-0 M of ammonium sulfate in buffer E at a flow rate of 0.5 ml/min . The eluate containing LUCT (4.2 ml)was applied to a reversed-phase column (Cosmosil 5 TMS-300, 4.5 0 x 250 mm) and eluted with CH3CN from 22 .3% to 60% containing 0.1% trifluoroacetic acid at a flow rate of 0.5 ml/min. These procedures were repeated for 750 ml of the concentrated crude LUCT: ®, chemotactic activity of a 310-fold diluted fractions with chemotactic medium ;
, absorbance at 210 nm ;
, a linear gradient of CH3CN (22.5-60%).
Molecular mass of LUCT was determined as a single band at ti 10 kD by SDS-PAGE (Fig. 2) , and its pI was determined as 10.7 by chromatofocusing . Comparing the chemotactic activity ofLUCT with that ofFMLP, the chemotactic activity of LUCT was 0.75 x 10-9 M for ED5o, a higher specific activity than that of the bacterial chemotactic peptide FMLP (5 x 10-9 M) (8), and comparable with that of human C5a (10-9 M) (9). We determined the amino acid sequence of N142-terminal 32 residues of LUCT and compared it with amino acid sequences of several chemotactic factors (Fig. 3) . The NH2-terminal sequence of LUCT was quite different from those of human C5a and C3b (10) . Recently, PMN chemotactic factors (MDNCF and monokine) from human peripheral leukocytes stimulated with LPS or Con A were isolated (11, 12) . NH2-terminal 42-and 20-amino acid sequences of MDNCF and the monokine have been determined, respectively. The NH2-terminal amino acid sequence from the sixth amino acid of LUCT was completely identical to the NH2-terminal sequence of either chemotactic factor, except for the 11th, 12th, and 31st amino acids. Considering the homology of the NH2-terminal amino acid sequences, the leukocyte-derived chemotactic factors could be hydrolyzed by a trypsin-like protease, resulting in des(1-5) of LUCT Moreover, the NH2-terminal amino acid of LUCT was Ala, and the NH2-terminal 32-amino acid sequence was extensively homologous to the 32-amino acid sequence of the protein consisting of 77 amino acids encoded by 3-10C cDNA derived from mRNA isolated from human leukocytes (13) . LUCT consisted of 75 (Trp was not tested) amino acids and this amino acid composition was similar to the reported amino acid composition deduced from the 3-10C cDNA sequence (Table II) . Schmid and Weissmann (13) have suggested that the NH2-terminal 22 amino acids are the sequence for signal peptide, and therefore, the 23rd amino acid Ala is the NH2 terminal of the mature protein consisting of 77 amino acids, strongly suggesting that the LUCTcoding gene structurally resembles the 3-10C cDNA in the carcinoma cells and that LUCT may be initially synthesized as a 99-amino acid protein and then the first 22-amino acid signal peptide may be removed upon extracellular secretion. The NH2-terminal sequence of five amino acids FIGURE 3 . A comparison of NH2-terminal amino acid sequence of various chemotactic proteins. 1, LUCT 2, MDNCF; 3, monokine ; 4, 3-10C-encoded protein; 5, 0-thromboglobulin; 6, platelet factor 4; 7, human C5a; 8, human C36. of LUCT was completely different from the corresponding amino acid sequences of both /3-thromboglobulin and platelet factor 4 ( Fig. 3) , although both have been suggested to be homologous to the sequence of 3-10C-encoded protein (13) . It should also be noted that the gene for LUCT is constitutively expressed in the human lung carcinoma cells without any added stimulant. On the other hand, the synthesis of the chemotactic factors in human leukocytes has been induced only by stimulation with LPS or Con A (11, 12) .
It has been observed that PMN first infiltrate into inflammatory sites when mice are intraperitoneally injected with stimulants such as glycogen and casein (5) . The infiltration of PMN into tumor-growing sites before infiltration ofmacrophages and lymphocytes has been also observed (1). Furthermore, Bottazzi et al. (4) have demonstrated from using tumor cell lines ofmouse and human origin, that there is a correlation between chemotactic activity for mononuclear phagocytes in supernatants of cultured cells and amount of tumor-associated macrophages in vivo. In addition, PMN have tumor killing activity in vitro (1). Hence, tumor-secreting LUCT might be involved in the first step of immunosurveillance by PMN in their host-defense function . Further study is needed to clarify the physiological role of LUCT, especially in terms of tumor-associated PMN. quential purification steps : DEAE-Sepharose, CM-Sepharose, HPLC on carboxylmethylated-polyvinylalcohol resin, hydrophobic, and reversed-phase. The molecular mass was determined as -10 kD by SDS-PAGE and isoelectric point was 10.7 . The chemotactic activity (ED5o 0.75 x 10-9 M) was sevenfold more potent than that of FMLP (5 x 10-9 M) and comparable with that of C5a (10-9 M). N142-terminal amino acid sequence and amino acid composition of LUCT strongly suggest that it may be closely related to the putative protein encoded by the cDNA clone (3-1OC) and almost identical with a part of sequence of the chemotactic factor derived from stimulated human leukocytes in the 6th to 32nd, but not the N1-12-terminal 5 amino acids . These results indicate that the carcinoma cells produce LUCT without any added stimulant and suggest that the previously isolated chemotactic monokines may correspond to des(1-5) of LUCT in the NH2-terminal region.
